Acarix AB (publ) publishes Interim Report, January – June 2020

For us and for many other companies, the pandemic and global uncertainty have caused delays in some
prioritized projects. However, in combination with a dynamic capital market this has created a window
for us to review our overall funding. The opportunity to secure funding will enable full focus with
continued commercialization in priority markets and continued the research as soon as the market is
normalized again.

Acarix Interim report Q2 2020

Acarix Delårsrapport Q2 2020

About Acarix
Acarix was establish in 2009 and is listed on Nasdaq First North Growth Market. Acarix's CADScor@System uses an advanced sensor placed on the skin above the heart to listen to the sounds of cardiac contraction movement and turbulent flow. It has been designed to be an all-in-on system in the sense that the heart signal will be recorded, processed, and displayed as a patient specific score, the CAD-score, on the device screen.